Gradient Investments’s Astera Labs ALAB Stock Holding History

Gradient Investments’s Portfolio ALAB Stock Details ALAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.48M	Buy	5,132 +605	+13%	+$161K	0.03%	245
2026 Q1	$496K	Buy	+4,527	New	+$645K	0.01%	351

Other funds holding ALAB

Salem Investment Counselors Winston Salem, North Carolina $4.03B AUM 61.49% 1-Year Est. Return

OFI Invest Asset Management Paris, France $10B AUM 48.47% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Tensor Edge Capital Weston, Massachusetts $1.51B AUM

M & L Capital Management London, United Kingdom $370M AUM 165.61% 1-Year Est. Return

Handelsbanken Fonder

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Linden Thomas Advisory Services Charlotte, North Carolina $1.24B AUM 47.37% 1-Year Est. Return

Wealthcare Advisory Partners West Chester, Pennsylvania $5.27B AUM 22.23% 1-Year Est. Return

Global X Japan Chiyoda-Ku, Tokyo, Japan $2.72B AUM 45.88% 1-Year Est. Return

Integrated Financial Solutions Reston, Virginia $185M AUM 67.6% 1-Year Est. Return

Gradient Investments's ALAB Position: Q2 2026 in Review

Gradient Investments increased its Astera Labs (ALAB) stake by 13% in Q2 2026, buying an estimated $161K and bringing the position to 5,132 shares worth $2.48M. The position accounts for 0.03% of the portfolio, ranked #245.

Gradient Investments first reported a position in ALAB in Q1 2026 and has held it in 2 quarters since. 107 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

Gradient Investments held 5,132 shares of Astera Labs worth $2.48M as of Q2 2026.
Gradient Investments bought 605 Astera Labs shares in Q2 2026, an estimated $161K.
Astera Labs made up 0.03% of Gradient Investments's portfolio in Q2 2026, its #245 holding.
Gradient Investments first reported a position in Astera Labs in Q1 2026 and has held it in 2 quarters since.
107 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Gradient Investments's 13F filing for Q2 2026, filed 8 Jul 2026.